Liver regeneration: From myth to mechanism

Nature Reviews Molecular Cell Biology

Volumn 5, Issue 10, 2004, Pages 836-847

  Taub, Rebecca ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAS LIGAND; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; SCATTER FACTOR; SOMATOMEDIN BINDING PROTEIN 1; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ACUTE PHASE RESPONSE; COMPLEMENT SYSTEM; GENE ACTIVATION; IMMEDIATE EARLY GENE; KUPFFER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER INJURY; LIVER PROTECTION; LIVER REGENERATION; MITOGENESIS; MOLECULAR GENETICS; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; REVIEW; STELLATE CELL;

ANIMALS; CELL CYCLE; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HEPATECTOMY; HUMANS; INTERLEUKIN-6; LIVER; LIVER REGENERATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 5044232017     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1489     Document Type: Review

References (130)

1. Saxema, R., Zucker, S. D. & Crawford, J. M. in Hepatology: A Textbook of Liver Disease, (eds Zakim, D. Z. & Boyer, T. D.) Ch. 1 (Saunders, Philadelphia, USA, 2003).
2. Higgins, G. M. & Anderson, R. M. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 12, 186-202 (1931). Original description of liver regeneration after partial hepatectomy, which is basically the same technique that is used today.
3. Michalopoulos, G. K. & DeFrances, M. C. Liver regeneration. Science 276, 60-66 (1997).
4. Taub, R., Greenbaum, L. E. & Peng, Y. Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin. Liver Dis. 19, 117-127 (1999).
5. Fausto, N. & Webber, E. M. in The Liver: Biology and Pathobiology (eds Arias, I. M., Boyer, J. L., Fausto, N., Jacoby, W. B., Schachter, D. & Shafritz, D. A.) 53-68 (Raven Press Ltd, New York, USA, 1994).
6. Taub, R. in Hepatology: A Textbook of Liver Disease. (eds Zakim, D. Z. & Boyer, W. B.) Ch. 2 (Saunders, Philadelphia, USA, 2003).
7. Koniaris, L. G., McKillop, I. H., Schwartz, S. I. & Zimmers, T. A. Liver regeneration. J. Am. Coll. Surg. 197, 634-659 (2003).
8. Fausto N. Lessons from genetically engineered animal models. V. Knocking out genes to study liver regeneration: present and future. Am. J. Physiol. 277, G917-G921 (1999).
9. Costa, R. H., Kalinichenko, V. V., Holterman, A.-X. L. & Wang, X. Transcription factors in liver development, differentiation, and regeneration. Hepatology 38, 1331-1347 (2003).
10. Sigal, S. H. et al. Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am. J. Physiol. 276, G1260-G1272 (1999).
11. Matsuo, T. et al. Control mechanism of the circadian clock for timing of cell division in vivo. Science 302, 255-259 (2003).
12. Grisham, J. W. A morphologic study of deoxyrobonucleic acid synthesis and cell proliferation in regenerating rat liver: autoradiography with thymidine-H. Cancer Res. 22, 842-849 (1962). Reports the critical timing of liver regeneration and assesses DNA synthesis in different cell types.
13. Dabeva, M. D. & Shafritz, D. A. Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration. Am. J. Pathol. 143, 1606-1620 (1993).
14. Fausto, N. Liver regeneration. J. Hepatol. 32 (Suppl. 1), 19-31 (2000).
15. Braun, K. M. & Sandgren, E. P. Cellular origin of regenerating parenchyma in a mouse model of severe hepatic injury. Am. J. Pathol. 157, 561-569 (2000).
16. Sandgren, E. P. et al. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 66, 245-256 (1991).
17. Overturf, K., Al-Dhalimy, M., Finegold, M. & Grompe, M. The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion. Am. J. Pathol. 155, 2135-2143 (1999).
18. Rudolph, K. L. et al. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 287, 1253-1258 (2000). Provides insight into the mechanism by which the replicative potential of hepatocytes is maintained through many generations.
19. Satyanarayana, A. et al. Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J. 22, 4003-4013 (2003).
20. Petersen, B. E. et al. Bone marrow as a potential source of hepatic oval cells. Science 284, 1168-1170 (1999).
21. Ilagasse, E. et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nature Med. 6, 1229-1234 (2000).
22. Vassilopoulos, G., Wang, P. R. & Russell, D. W. Transplanted bone marrow regenerates liver by cell fusion. Nature 922, 901-904 (2003).
23. Fausto, N. & Campbell, J. S. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech. Dev. 120, 117-130 (2003).
24. Moolten, F. L. & Bucher, N. L. Regeneration of rat liver: transfer of humoral agent by cross circulation. Science 158, 272-274 (1967). An important article, which established that circulating factors can induce liver regeneration. This subsequently led to efforts to identify and isolate hepatocyte growth factors.
25. Haber, B. A., Mohn, K. L., Diamond, R. H. & Taub, R. Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J. Clin. Invest. 91, 1319-1326 (1993).
26. Su, A. I., Guidotti, L. G., Pezacki, J. P., Chisari, F. V. & Schultz, P. G. Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice. Proc. Natl Acad. Sci. USA 99, 11181-11186 (2002).
27. Kelley-Loughnane, N., Sabla, G. E., Ley-Ebert, C., Aronow, B. J. & Bezerra, J. A. Independent and overlapping transcriptional activation during liver development and regeneration in mice. Hepatology 35, 525-534 (2002).
28. Arai, M. et al. Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration. J. Biol. Chem. 278, 29813-29818 (2003).
29. Currier, A. R. et al. Plasminogen directs the pleiotropic effects of uPA in liver injury and repair. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G508-G515 (2003).
30. Wheeler, M. D. et al. Impaired Ras membrane association and activation in PPARα knockout mice after partial hepatectomy. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G302-G312 (2003).
31. Bustos, M. et al. Protection against liver damage by cardiotrophin-1, a hepatocyte survival factor up-regulated in the regenerating liver in rats. Gastroenterology 125, 192-201 (2003).
32. Leclercq, I. A., Field, J. & Farrell, G. C. Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury. Gastroenterology 124, 1451-1464 (2003).
33. Kiso, S. et al. Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology 124, 701-707 (2003).
34. Schwabe, R. F. et al. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 37, 824-832 (2003).
35. 4 injury. Hepatology 37, 107-117 (2003).
36. Malik, R., Mellor, N., Selden, C. & Hodgson, H. Triiodothyronine enhances the regenerative capacity of the liver following partial hepatectomy. Hepatology 37, 79-86 (2003).
37. Nelsen, C. J., Rickheim, D. G., Tucker, M. M., Hansen, L. K. & Albrecht, J. H. Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes. J. Biol. Chem. 278, 3656-3663 (2003). Shows that TOR could be an important factor in establishing liver size.
38. Leu, J. I., Crissey, M. A., Craig, L. E. & Taub, R. Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBPβ and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol. Cell. Biol. 23, 1251-1259 (2003).
39. Ren, X., Carpenter, A., Hogaboam, C. & Colletti, L. Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am. J. Pathol. 163, 563-570 (2003).
40. Casado, M. et al. Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy. FASEB J. 15, 2016-2018 (2001).
41. Hogaboam, C. M. et al. Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines. FASEB J. 13, 1565-1574 (1999).
42. Selzner, N. et al. ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-α/IL-6 in mice. Gastroenterology 124, 692-700 (2003).
43. INK4c collaborates with other CDK-inhibitory proteins in the regenerating liver. Hepatology 37, 833-841 (2003).
44. Anderson, S. P. et al. Delayed liver regeneration in peroxisome proliferator-activated receptor-α-null mice. Hepatology 36, 544-554 (2002).
45. Behrens, A. et al. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J. 21, 1782-1790 (2002). Together with other studies, this article shows the significance of Jun in providing an important link between immediate-early genes and DNA synthesis.
46. Shimizu, M. et al. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology 33, 569-576 (2001).
47. Ren, X., Hogaboam, C., Carpenter, A. & Colletti, L. Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy. J. Clin. Invest. 112, 1407-1418 (2003). Establishes a potentially important link between IL-6 and a downstream growth factor, which could link the cytokine- and growth-factor-mediated pathways.
48. Strey, C. W. et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 198, 913-923 (2003).
49. Temme, A., Ott, T., Dombrowski, F. & Willecke, K. The extent of synchronous initiation and termination of DNA synthesis in regenerating mouse liver is dependent on connexin32 expressing gap junctions. J. Hepatol. 32, 627-635 (2000).
50. Mastellos, D., Papadimitriou, J. C., Franchini, S., Tsonis, P. A. & Lambris, J. D. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J. Immunol. 166, 2479-2486 (2001).
51. Kip1 accelerates DNA replication after partial hepatectomy in mice. J. Surg. Res. 111, 196-202 (2003).
52. Imai, T., Jiang, M., Kastner, P., Chambon, P. & Metzger, D. Selective ablation of retinoid X receptor α in hepatocytes impairs their lifespan and regenerative capacity. Proc. Natl Acad. Sci. USA 98, 4581-4586 (2001).
53. LeCouter, J. et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 299, 890-893 (2003).
54. Wang, X., Kiyokawa, H., Dennewitz, M. B. & Costa, R. H. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc. Natl Acad. Sci. USA 99, 16881-16886 (2002).
55. Cressman, D. E. et al. Liver failure and defective hepatocyte regeneration in interteukin-6-deficient mice. Science 274, 1379-1383 (1996). The first study to link the cytokine IL-6 to liver regeneration.
56. Yamada Y. et al. Initiation of liver growth by tumor necrosis factor: defective liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl Acad. Sci. USA 94, 1441-1446 (1997). Establishes the critical link between cytokine activation and liver regeneration.
57. Greenbaum, L. E. et al. CCAAT enhancer-binding protein β is required for normal hepatocyte proliferation in mice after partial hepatectomy. J. Clin. Invest. 102, 996-1007 (1998).
58. Smith, A. J., Ronald, P. J. & Elferink, O. Liver gene disruption: winners by KO? J. Hepatology 31, 752-759 (1999).
59. Loranger, A. et al. Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am. J. Pathol. 151, 1673-1683 (1997).
60. Reimold, A. M. et al. An essential role in liver development for transcription factor XBP-1. Genes Dev. 14, 152-157 (2000).
61. Rai, R. M. et al. Impaired liver regeneration in inducible nitric oxide synthase-deficient mice. Proc. Natl Acad. Sci. USA 95, 13829-13834 (1998).
62. Ueki, T. et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Med. 5, 226-230 (1999).
63. Matsuda, Y. et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26, 81-89 (1997).
64. Beg, A. A. et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170 (1995). Establishes the importance of NFκB in hepatoprotection against apoptosis.
65. DeAngelis, R. A., Kovalovich, K., Cressman, D. E. & Taub, R. Normal liver regeneration in p50/nuclear factor κB1 knockout mice. Hepatology 33, 915-924 (2001).
66. Li, W., Liang, X., Kellendonk, C., Poli, V. & Taub, R. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J. Biol. Chem. 277, 28411-28417 (2002).
67. Servillo, G., Della Fazia, M. A. & Sassone-Corsi, P. Transcription factor CREM coordinates the timing of hepatocyte proliferation in the regenerating liver. Genes Dev. 12, 3639-3643 (1998).
68. Levy, D. E. & Lee, C. K. What does Stat3 do? J. Clin. Invest. 109, 1143-1148 (2002).
69. Heinrich, P. C. et al. Principles of Interteukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1-20 (2003).
70. Sakamoto, T. et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 29, 403-411 (1999).
71. Wuestefeld, T. et al. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J. Biol. Chem. 278, 11281-11288 (2003).
72. Blindenbacher, A. et al. Interleukin-6 is important for survival after partial hepatectomy in mice. Hepatology 38, 674-682 (2003).
73. 1 phase progression in proliferating hepatocytes. Mol. Cell. Biol. 19, 6003-6011 (1999).
74. Fujita, J. et al. Effect of TNF gene depletion on liver regeneration after partial hepatectomy in mice. Surgery 129, 48-54 (2001).
75. Aldeguer, X. et al. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology 35, 40-48 (2002).
76. Cornell, R. P., Lilijequist, B. L. & Bartizal, K. F. Depressed liver regeneration after partial hepatectomy in germ-free athymic and lipopolysaccharide-resistant mice. Hepatology 11, 916-922 (1990).
77. Fujita, T. Evolution of the lectin-complement pathway and its role in innate immunity. Nature Rev. Immunol. 2, 346-353 (2002).
78. Li, W. et al. Global changes in interleukin-6 dependent gene expression patterns in mouse liver after partial hepatectomy. Hepatology 33, 1377-1386 (2001).
79. Galun, E., Zeira, E., Pappo, O., Peters, M. & Rose-John, S. Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury. FASEB J. 14, 1979-1987 (2000).
80. Maione, D. et al. Coexpression of IL-6 and soluble IL-6 receptor causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J. 17, 5588-5597 (1998).
81. Peters, M. et al. Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. Gastroenterology 119, 1663-1671 (2000).
82. Zimmers, T. A., McKillop, I. H., Pierce, R. H., Yoo, J. Y. & Koniaris, L. G. Massive liver growth in mice induced by systemic interleukin-6 administration. Hepatology 38, 326-334 (2003).
83. Zimmers, T. A., Pierce, R. H., McKillop, I. H. & Koniaris, L. G. Resolving the role of IL-6 in liver regeneration. Hepatology 38, 1590-1591 (2003).
84. Huh, C. et al. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl Acad. Sci. USA 101, 4477-4482 (2004).
85. Pediaditakis, P., Lopez-Talavera, J. C., Petersen, B., Monga, S. P. & Michalopoulos, G. K. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 34, 688-693 (2001). Shows the mechanism by which HGF is rapidly activated after partial hepatectomy.
86. Burr, A. W. et al. Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration. J. Pathol. 185, 298-302 (1998). Shows a requirement for HGF during liver regeneration.
87. Okano, J. et al. Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. Biochem. Biophys. Res. Commun. 309, 298-304 (2003).
88. Scheving, L. A., Stevenson, M. C., Taylormoore, J. M., Traxler, P. & Russell, W. E. Integral role of the EGF receptor in HGF-mediated hepatocyte proliferation. Biochem. Biophys. Res. Commun. 290, 197-203 (2002).
89. Tomiya, T. et al. The mitogenic activity of hepatocyte growth factor on rat hepatocytes is dependent upon endogenous transforming growth factor-α. Am. J. Pathol. 157, 1693-1701 (2000). Establishes a connection between HGF and the induction of a potent hepatocyte mitogen, TGFα.
90. Diehl, A. M. et al. Tumor necrosis factor-α induced c-jun during the regenerative response to liver injury. Am. J. Physiol. 267, G552-G561 (1994).
91. Leu, J. I., Crissey, M. A. S., Leu, J. P., Ciliberto, G. & Taub, R. Interleukin-6-induced Stat3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol. Cell. Biol. 21, 414-424 (2001). This study might ultimately provide important insight into the maintenance of hepatic function during liver regeneration.
92. Weir, E. et al. Rapid induction of mRNAs for liver regeneration factor (LRF-1) and insulin-like growth factor binding protein-1 (IGFBP-1) in primary cultures of rat hepatocytes by hepatocyte growth factor and epidermal growth factor. Hepatology 20, 955-960 (1994).
93. Kovalovich, K. et al. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 31, 149-159 (2000).
94. Camargo, C. A. et al. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26, 1513-1520 (1997).
95. Debonera, F. et al. Activation of interleukin-6/Stat3 and liver regeneration following transplantation. J. Surg. Res. 96, 289-295 (2001).
96. Selzner, M., Camargo, C. A. & Clavien, P-A. Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology 30, 469-175 (1999).
97. Ezure, T. et al. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am. J. Pathol. 156, 1627-1639 (2000).
98. Mizuhara, H. et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179, 1529-1537 (1994).
99. Pfeffer, K. et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457-467 (1993).
100. Yamada, Y. & Fausto, N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am. J. Pathol. 152, 1577-1589 (1998).
101. Czaja, M. J., Xu, J. & Alt, E. Prevention of carbon tetrachloride induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 108, 1849-1854 (1995).
102. Iimuro, Y. et al. NFκB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101, 802-811 (1998).
103. Maeda, S. et al. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19, 725-737 (2003).
104. Shi, J. et al. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am. J. Pathol. 153, 515-525 (1998).
105. Kovalovich, K. et al. IL-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2 and Bcl-xL. J. Biol. Chem. 276, 26605-26613 (2001).
106. Haga, S. et al. Stat3 protects against Fas-induced liver injury by redox-dependent and indepent mechanisms. J. Clin. Invest. 112, 989-998 (2003). Establishes the mechanisms for hepatoprotection by IL-6 and STAT3.
107. Taub, R. Hepatoprotection via the IL-6/Stat3 pathway J. Clin. Invest. 112, 978-980 (2003).
108. Leu, J. I., Crissey, M. A. & Taub, R. Massive hepatic apoptosis associated with TGF-β1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J. Clin. Invest. 111, 129-139 (2003). Reports new hepatoprotective properties of IGFBP1 and plausible mechanisms.
109. Corpechot, C. et al. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis. Am. J. Pathol. 160, 613-620 (2002).
110. Phaneuf, D., Chen, S. J. & Wilson, J. M. Intravenous injection of an adenovirus encoding hepatocyte growth factor results in liver growth and has a protective effect against apoptosis. Mol. Med. 6, 96-103 (2000).
111. Xue, F. et al. Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 52, 694-700 (2003).
112. Wang, X. et al. A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol. Cell 9, 411-421 (2002).
113. Ozaki, M., Haga, S., Zhang, H. Q., Irani, K. & Susuki, S. Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1. Cell Death Differ. 10, 508-515 (2003).
114. Haber, B. A. et al. High levels of glucose-6-phosphatase gene and protein expression in proliferating liver and diabetes. J. Clin. Invest. 95, 832-841 (1995).
115. Rosa, J. L., Bartrons, R. & Tauler, A. Gene expression of regulatory enzymes of glycolysis/gluconeogenesis in regenerating rat liver. Biochem. J. 287, 113-116 (1992).
116. Diehl, A. M. & Yang, S. Q. Regenerative changes in C/EBPα and C/EBPβ expression modulate binding to the C/EBP site in the c-fos promoter. Hepatology 19, 447-456 (1994).
117. Greenbaum, L. E. et al. Coexistence of C/EBP isoforms, growth-induced proteins and DNA synthesis in hepatocytes during liver regeneration: implications for maintenance of the differentiated state during cell growth. J. Clin. Invest. 96, 1351-1365 (1995).
118. Mischoulon, D. et al. Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBPα) gene expression during hepatocyte proliferation in the regenerating liver and in culture. Mol. Cell. Biol. 12, 2553-2560 (1992).
119. Martinez-Hernandez, A. & Amenta, P. S. The extracellular matrix in hepatic regeneration. FASEB J. 9, 1401-1410 (1995).
120. Bezerra, J. A. et al. Plasminogen activators direct reorganization of the liver lobule after acute injury. Am. J. Pathol. 158, 921-929 (2001).
121. Campbell, J. S. et al. Expression of suppressors of cytokine signaling during liver regeneration. J. Clin. Invest. 107, 1285-1292 (2001). Provides a potential mechanism for turning off IL-6 during liver regeneration.
122. Wustefeld, T. et al. Hyperstimulation with interleukin-6 inhibits cell cycle progression after hepatectomy in mice. Hepatology 32, 514-522 (2000).
123. Derynck, R. & Zhang, Y. E. Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature 425, 577-584 (2003).
124. Houck, K. A., Cruise, J. L. & Michalopoulos, G. K. Norepinephrine modulates the growth-inhibitory effect of transforming growth factor-β in primary hepatocyte cultures. J. Cell Physiol. 135, 551-555 (1988).
125. Macias-Silva, M., Li, W., Leu, J. I., Crissey, M. A. & Taub, R. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-β signals during liver regeneration. J. Biol. Chem. 277, 28483-28490 (2002).
126. Date, M. et al. Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. J. Hepatol. 32, 251-260 (2000).
127. Takabe, K. et al. Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats. Hepatology 38, 1107-1115 (2003). Provides important insight into how the follistatin-activin system might regulate liver size.
128. Pascher, A. et al. Donor evaluation, donor risks, donor outcome, and donor quality of life in adult-to-adult living donor liver transplantation. Liver Transpl. 8, 829-837 (2002).
129. Olthoff, K. M. Hepatic regeneration in living donor liver transplantation Liver Transpl. 9 S35-S41 (2003).
130. Weglarz, T. C., & Sandgren, E. P. Timing of hepatocyte entry into DNA synthesis after partial hepatectomy is cell autonomous. Proc. Natl Acad. Sci. USA 97, 12595-12600 (2000).